Please use this identifier to cite or link to this item:
|Statistics||SHARE CORE MendeleyBASE||
|Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE|
Autophagic dysfunction in Papillon Lefèvre syndrome is restored by recombinant Cathepsin C treatment
|Authors:||Bullón, Pedro; Castejón-Vega, Beatriz; Román-Malo, Lourdes; Jiménez-Guerrero, Maripaz; Cotán, David CSIC ORCID; Forbes-Hernandez, Tamara Y.; Varela‐López, Alfonso; Pérez-Pulido, Antonio J. CSIC ORCID ; Giampieri, Francesca; Quiles, José Luis; Battino, Maurizio; Sánchez-Alcázar, José Antonio CSIC ORCID; Cordero, Mario D. CSIC ORCID|
|Citation:||Journal of Allergy and Clinical Immunology 142(4): 1131-1143.e7 (2018)|
|Abstract:||[Background]: Cathepsin C (CatC) is a lysosomal enzyme involved in activation of serine proteases from immune and inflammatory cells. Several loss-of-function mutations in the CatC gene have been shown to be the genetic mark of Papillon-Lefèvre syndrome (PLS), a rare autosomal recessive disease characterized by severe early-onset periodontitis, palmoplantar hyperkeratosis, and increased susceptibility to infections. Deficiencies or dysfunction in other cathepsin family proteins, such as cathepsin B or D, have been associated with autophagic and lysosomal disorders.|
[Objectives]: Here we characterized the basis for autophagic dysfunction in patients with PLS by analyzing skin fibroblasts derived from patients with several mutations in the CatC gene and reduced enzymatic activity.
[Methods]: Skin fibroblasts were isolated from patients with PLS assessed by using genetic analysis. Authophagic flux dysfunction was evaluated by examining accumulation of p62/SQSTM1 and a bafilomycin assay. Ultrastructural analysis further confirmed abnormal accumulation of autophagic vesicles in mutant cells. A recombinant CatC protein was produced by a baculovirus system in insect cell cultures.
[Results]: Mutant fibroblasts from patients with PLS showed alterations in oxidative/antioxidative status, reduced oxygen consumption, and a marked autophagic dysfunction associated with autophagosome accumulation. These alterations were accompanied by lysosomal permeabilization, cathepsin B release, and NLR family pyrin domain containing 3 (NLRP3) inflammasome activation. Treatment of mutant fibroblasts with recombinant CatC improved cell growth and autophagic flux and partially restored lysosomal permeabilization.
[Conclusions]: Our data provide a novel molecular mechanism underlying PLS. Impaired autophagy caused by insufficient lysosomal function might represent a new therapeutic target for PLS.
|Publisher version (URL):||http://dx.doi.org/10.1016/j.jaci.2018.01.018|
|Appears in Collections:||(CABD) Artículos|